SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 3-YEAR EFFICACY AND SAFETY RESULTS FROM PHASE 3 FUTURE 1 TRIAL

被引：7
|
作者：
Mease, P. J. [1 ,2 ]
Kavanaugh, A. [3 ]
Reimold, A. [4 ]
Tahir, H. [5 ]
Rech, J. [6 ]
Hall, S. [7 ]
Geusens, P. [8 ,9 ]
Pascale, P. [10 ]
Delicha, E. M. [10 ]
Pricop, L. [11 ]
Mpofu, S. [10 ]
机构：
[1] Swedish Med Ctr, Seattle, WA USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] UC San Diego Sch Med, La Jolla, CA USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[5] Barts Hlth NHS Trust, London, England
[6] Univ Erlangen Nurnberg, Erlangen, Germany
[7] Monash Univ, Melbourne, Vic, Australia
[8] Univ Hasselt, Hasselt, Belgium
[9] Maastricht Univ Hosp, Maastricht, Netherlands
[10] Novartis Pharma AG, Basel, Switzerland
[11] Novartis Pharmaceut, E Hanover, NJ USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.1260
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0470
引用
收藏
页码：952 / 953
页数：2
相关论文
共 50 条
  • [41] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN WORK PRODUCTIVITY AND HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM FUTURE 1 AND FUTURE 2
    Strand, V.
    FitzGerald, O.
    Coates, L. C.
    Walsh, J. A.
    Canete, J. D.
    Bhosekar, V.
    Pricop, L.
    Gandhi, K.
    Jugl, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 688 - 688
  • [42] SECUKINUMAB PROVIDES RAPID AND SUSTAINED IMPROVEMENTS IN SUBGROUP ANALYSES OF JOINT TENDERNESS AND SWELLING IN PATIENTS WITH PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM THE PHASE 3 FUTURE 5 STUDY
    McInnes, Iain
    Chinoy, Hector
    Asquith, Darren
    White, Abigail
    Gaillez, Corine
    RHEUMATOLOGY, 2021, 60
  • [43] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS IN ANTI-TNF-NAIVE PATIENTS AND THOSE PREVIOUSLY EXPOSED TO ANTI-TNF THERAPY: 52-WEEK RESULTS FROM AN INTERNATIONAL PHASE 3 TRIAL
    Kavanaugh, Arthur
    Kivitz, Alan
    McInnes, Iain B.
    Mease, Philip
    Mpofu, Shephard
    Wang, Zailong
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (03) : 141 - 142
  • [44] Secukinumab 150 mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis with Consistent Safety Profile and High Retention Rate: 4-Year Results from a Phase III Trial
    Marzo-Ortega, Helena
    Sieper, Joachim
    Kivitz, Alan J.
    Blanco, Ricardo
    Cohen, Martin
    Delicha, Evie Maria
    Rohrer, Susanne
    Richards, Hanno
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [45] Relationship Between Improvements in Fatigue and Signs & Symptoms of Active Psoriatic: Arthritis a Sub-Analysis of a Phase 3 Study with Secukinumab
    Gossec, Laure
    Kvien, Tore K.
    Conaghan, Philip G.
    Ostergaard, Mikkel
    Canete, Juan D.
    Gaillez, C.
    Mpofu, Shephard
    Sherif, Bintu
    Jugl, Steffen
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [46] Secukinumab Provides Clinical Improvements in Patients with Active Oligoarticular Psoriatic Arthritis: Results from a Pooled Analysis of 5 Phase 3 Studies
    Ogdie, Alexis
    Gladman, Dafna
    Coates, Laura
    Pournara, Effie
    Meng, Xiangyi
    Parikh, Bhumik
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3812 - 3815
  • [47] SECUKINUMAB PROVIDES CLINICAL IMPROVEMENTS IN PATIENTS WITH ACTIVE OLIGOARTICULAR PSORIATIC ARTHRITIS: RESULTS FROM A POOLED ANALYSIS OF FIVE PHASE 3 STUDIES
    Coates, Laura C.
    Ogdie, Alexis
    Gladman, Dafna D.
    Pournara, Effie
    Meng, Xiangyi
    Parikh, Bhumik
    Mease, Philip J.
    RHEUMATOLOGY, 2022, 61
  • [48] Secukinumab Provides Sustained Improvements in Clinical and Imaging Outcomes in Patients with Psoriatic Arthritis and Axial Manifestations: Results from the MAXIMISE Trial
    Baraliakos, Xenofon
    Gossec, Laure
    Pournara, Effie
    Jeka, Slawomir
    Blanco, Ricardo
    D'Angelo, Salvatore
    Schett, Georg
    Schulz, Barbara
    Rissler, Michael
    Whyms, Dermot
    Perella, Chiara
    Coates, Laura
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [49] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN CLINICAL AND IMAGING OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS: RESULTS FROM THE MAXIMISE TRIAL
    Baraliakos, Xenofon
    Gossec, Laure
    Pournara, Effie
    Jeka, Slawomir
    Blanco, Ricardo
    D'Angelo, Salvatore
    Schett, Georg
    Schulz, Barbara
    Rissler, Michael
    Whyms, Dermot
    Perella, Chiara
    Coates, Laura C.
    RHEUMATOLOGY, 2021, 60 : 98 - 98
  • [50] Secukinumab improves signs and symptoms of psoriatic arthritis: Results of phase 3 FUTURE 2 study stratified by concomitant methotrexate use
    Gottlieb, Alice B.
    McInnes, Iain
    Mease, Philip
    Mpofu, Shephard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB270 - AB270
12345